- NEWS AND VIEWS
Teamwork by different T-cell types boosts tumour destruction by immunotherapy
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 574, 639-640 (2019)
doi: https://doi.org/10.1038/d41586-019-03106-1
References
Alspach, E. et al. Nature 574, 696–701 (2019).
Borst, J., Ahrends, T., Bąbała, N., Melief, C. J. M. & Kastenmüller, W. Nature Rev. Immunol. 18, 635–647 (2018).
Tran, E. et al. Science 344, 641–645 (2014).
Gubin, M. M. et al. Nature 515, 577–581 (2014).
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K. & Oliveira, M. J. Front. Immunol. 9, 847 (2018).
Gubin, M. M. et al. Cell 175, 1014–1030 (2018).
Corthay, A. et al. Immunity 22, 371–383 (2005).
Garris, C. S. et al. Immunity 49, 1148–1161 (2018).
Ott, P. A. et al. Nature 547, 217–221 (2017).
Abelin, J. G. et al. Immunity https://doi.org/10.1016/j.immuni.2019.08.012 (2019).
Competing Interests
J.L.L. and L.D. are employees of Genentech.